SG Americas Securities
JANX icon

SG Americas Securities’s Janux Therapeutics JANX Stock Holding History

SG Americas Securities’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$450K Sell
29,278
-2,255
-7% -$32.7K ﹤0.01% 2381
2026
Q1 		$438K Sell
31,533
-48,284
-60% -$662K ﹤0.01% 2252
2025
Q4 		$1.1M Buy
79,817
+50,802
+175% +$1.19M ﹤0.01% 1935
2025
Q3 		$709K Buy
29,015
+20,673
+248% +$503K ﹤0.01% 1791
2025
Q2 		$193K Sell
8,342
-20,289
-71% -$535K ﹤0.01% 2276
2025
Q1 		$773K Buy
+28,631
New +$1.08M ﹤0.01% 1406
2024
Q4 		– Sell
-5,738
Closed -$261K – 3360
2024
Q3 		$261K Sell
5,738
-28,926
-83% -$1.26M ﹤0.01% 2259
2024
Q2 		$1.45M Buy
+34,664
New +$1.63M 0.01% 1125
2024
Q1 		– Sell
-9,345
Closed -$100K – 3201
2023
Q4 		$100K Buy
+9,345
New +$80.8K ﹤0.01% 2767
2023
Q1 		– Sell
-7,902
Closed -$104K – 3411
2022
Q4 		$104K Buy
+7,902
New +$116K ﹤0.01% 2694
2021
Q4 		– Sell
-65,414
Closed -$1.42M – 3598
2021
Q3 		$1.42M Buy
+65,414
New +$1.88M 0.01% 1598

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

SG Americas Securities's JANX Position: Q2 2026 in Review

SG Americas Securities reduced its Janux Therapeutics (JANX) stake by 7.2% in Q2 2026, selling an estimated $32.7K and leaving 29,278 shares worth $450K. The position accounts for ﹤0.01% of the portfolio, ranked #2381.

SG Americas Securities first reported a position in JANX in Q3 2021 and has held it in 11 quarters since. The position peaked at $1.45M in Q2 2024. 198 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

  • SG Americas Securities held 29,278 shares of Janux Therapeutics worth $450K as of Q2 2026.
  • SG Americas Securities sold 2,255 Janux Therapeutics shares in Q2 2026, an estimated $32.7K.
  • Janux Therapeutics made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #2381 holding.
  • SG Americas Securities first reported a position in Janux Therapeutics in Q3 2021 and has held it in 11 quarters since.
  • SG Americas Securities's Janux Therapeutics position peaked at $1.45M in Q2 2024.
  • 198 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.